VERA THERAPEUTICS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$30.98
+1.47%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-0.0%
3 months
-3.9%
6 months
-12.0%
1 year
+4.4%
Year to date
-38.8%
52-week range
$24.10 – $55.67
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$2.23B
P/E
-5.6
P/B
5.5
P/S
—
Revenue
$0
Net income
-$401.9M
Diluted EPS
-5.86
Gross margin
—
Net margin
—
Return on equity
-84.10%
Total debt
$75.23M
Cash
$48.88M
Free cash flow
-$339.18M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $0 | -$109.47M | — | — | -$100.37M |
| Mar 31, 2026 | $0 | -$121.03M | — | — | -$106.67M |
| Dec 31, 2025 | $0 | -$91.1M | — | — | -$70.1M |
| Sep 30, 2025 | $0 | -$80.29M | — | — | -$62.04M |
| Jun 30, 2025 | $0 | -$76.53M | — | — | -$55.01M |
| Mar 31, 2025 | $0 | -$51.69M | — | — | -$54.59M |
| Dec 31, 2024 | $0 | -$43.43M | — | — | -$39.83M |
| Sep 30, 2024 | $0 | -$46.63M | — | — | -$37.12M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent VERA news
All market newsNo ticker-linked stories are in the current archive.